Regulatory T Lymphocytes Are Associated with Less Aggressive Histologic Features in Microsatellite-Unstable Colorectal Cancers

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Tougeron, David ^a,b,c   Maby, Pauline ^a   Elie, Nicolas ^d   Fauquembergue, Émilie ^a   Le Pessot, Florence ^a   Cornic, Marie ^e   Sabourin, Jean Christophe ^a   Michel, Pierre ^a   Frébourg, Thierry ^a   Latouche, Jean Baptiste ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE POITIERS   (France)

^d UNIVERSITÉ DE CAEN   (France)

^e CENTRE HENRI BECQUEREL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CD3+ T LYMPHOCYTE; CELL DENSITY; COLLOID CARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; OVERALL SURVIVAL; REGULATORY T LYMPHOCYTE; SURVIVAL RATE; SURVIVAL TIME; T LYMPHOCYTE SUBPOPULATION; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR VOLUME; VASCULAR EMBOLUS LYMPHATIC INVASION PERINERVOUS INVASION CRITERIA; CELL COUNT; COLORECTAL TUMOR; CYTOLOGY; GENETICS; IMMUNOLOGY; PATHOLOGY;

AGED; CELL COUNT; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY;

EID: 84876191473     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061001     Document Type: Article

References (41)

1. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, et al. (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 22: 2654-66.
2. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, et al. (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313: 1960-4.
3. Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, et al. (2011) Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol 29: 610-8.
4. Sinicrope FA, Rego RL, Ansell SM, Knutson KL, Foster NR, et al. (2009) Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterology 137: 1270-9.
5. Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, et al. (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 71: 1263-71.
6. Greenson JK, Huang SC, Herron C, Moreno V, Bonner JD, et al. (2009) Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol 33: 126-33.
7. Smyrk TC, Watson P, Kaul K, Lynch HT, (2001) Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 91: 2417-22.
8. Michael-Robinson JM, Biemer-Huttmann A, Purdie DM, Walsh MD, Simms LA, et al. (2001) Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut 48: 360-6.
9. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, et al. (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342: 69-77.
10. Benatti P, Gafà R, Barana D, Marino M, Scarselli A, et al. (2005) Microsatellite instability and colorectal cancer prognosis. Clin Cancer Res 11: 8332-40.
11. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, et al. (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338: 1481-7.
12. Schwitalle Y, Kloor M, Eiermann S, Linnebacher M, Kienle P, et al. (2008) Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 134: 988-97.
13. Tougeron D, Fauquembergue E, Rouquette A, Le Pessot F, Sesboüé R, et al. (2009) Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations. Mod Pathol 22: 1186-95.
14. Guidoboni M, Gafà R, Viel A, Doglioni C, Russo A, et al. (2001) Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol 159: 297-304.
15. Dolcetti R, Viel A, Doglioni C, Russo A, Guidoboni M, et al. (1999) High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol 154: 1805-1813.
16. Drescher KM, Sharma P, Watson P, Gatalica Z, Thibodeau SN, et al. (2009) Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer. Fam Cancer 8: 231-9.
17. Phillips SM, Banerjea A, Feakins R, Li SR, Bustin SA, et al. (2004) Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br J Surg 91: 469-75.
18. Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette MT, et al. (2008) High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 57: 772-9.
19. Baker K, Zlobec I, Tornillo L, Terracciano L, Jass JR, et al. (2007) Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathway. Eur J Cancer 43: 624-31.
20. Buhard O, Cattaneo F, Wong YF, Yim SF, Friedman E, et al. (2006) Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. J Clin Oncol 24: 241-51.
21. Lugli A, Karamitopoulou E, Panayiotides I, Karakitsos P, Rallis G, et al. (2009) CD8+ lymphocytes/tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer. Br J Cancer 101: 1382-92.
22. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, et al. (1998) CD8+ T-cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58: 3491-3494.
23. Prall F, Duhrkop T, Weirich V, Ostwald C, Lenz P, et al. (2004) Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability. Hum Pathol 35: 808-16.
24. Takemoto N, Konishi F, Yamashita K, Kojima M, Furukawa T, et al. (2004) The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration. Jpn J Clin Oncol 34: 90-8.
25. Radoja S, Saio M, Schaer D, Koneru M, Vukmanovic S, et al. (2001) CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. J Immunol 167: 5042-51.
26. Ye SW, Wang Y, Valmori D, Ayyoub M, Han Y, et al. (2006) Ex-vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin content. J Clin Immunol 26: 447-56.
27. Koch M, Beckhove P, Op den Winkel J, Autenrieth D, Wagner P, et al. (2006) Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ. Ann Surg 244: 986-92.
28. Diederichsen AC, Hjelmborg JB, Christensen PB, Zeuthen J, Fenger C, (2003) Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother 52: 423-8.
29. Katz SC, Pillarisetty V, Bamboat ZM, Shia J, Hedvat C, et al. (2009) T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases. Ann Surg Oncol 16: 2524-30.
30. von Boehmer H, (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol 6: 338-44.
31. Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, et al. (2006) CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS One 1: e129.
32. Ling KL, Pratap SE, Bates GJ, Singh B, Mortensen NJ, et al. (2007) Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun 28: 7.
33. Loddenkemper C, Schernus M, Noutsias M, Stein H, Thiel E, et al. (2006) In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer. J Transl Med 4: 52.
34. Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, et al. (2009) Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Gut 58: 520-9.
35. Salama P, Phillips M, Grieu F, Morris M, Zeps N, et al. (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27: 186-92.
36. Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, et al. (2009) High frequency of tumor infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer 126: 2635-2643.
37. Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, et al. (2010) Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol 222: 350-66.
38. Michel S, Linnebacher M, Alcaniz J, Voss M, Wagner R, et al. (2010) Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes. Int J Cancer 127: 889-98.
39. Mantovani A, Garlanda C, Allavena P, (2010) Molecular pathways and targets in cancer-related inflammation. Ann Med 42: 161-70.
40. Blatner NR, Mulcahy MF, Dennis KL, Scholtens D, Bentrem DJ, et al. (2012) Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med 4: 164-159.
41. QUASAR Collaborative Group (2000) Comparison on fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. Lancet 355: 1588-1596.